![Dong Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 139 332 $ al 31/05/2026
Dong Wu is currently an Independent Non-Executive Director at Alphamab Oncology, a position held since 2019.
Education history includes an MBA from China Europe International Business School, conferred in 2005, and an undergraduate degree from Fudan University, conferred in 1992.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ALPHAMAB ONCOLOGY 0,01 % | 29/05/2025 | 120.000 ( 0,01 % ) | 139 332 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALPHAMAB ONCOLOGY | Director/Miembro de la Junta | 24/11/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
China Europe International Business School
 China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alphamab Oncology
 Alphamab Oncology BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in development manufacturing and commercialization of therapeutics for cancer treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
